Aksamit AJ (2001). Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J NeuroVirol
7: 386–390.
CAS
Article
PubMed
Google Scholar
Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998a). Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol
44: 341–349.
CAS
Article
PubMed
Google Scholar
Berger JR, Pall L, Lanska D, Whiteman M (1998b). Progressive multifocal leukoencephalopathy in patients with HIV infection. J NeuroVirol
4: 59–68.
CAS
Article
PubMed
Google Scholar
Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM (2000). Central nervous system complications in liver transplant recipients—incidence, timing, and long-term follow-up. Clin Transplant
14: 1–7.
CAS
Article
PubMed
Google Scholar
De Luca A, Giancola ML, Ammassari A, Grisetti S, Paglia MG, Gentile M, Cingolani A, Murri R, Liuzzi G, Monforte AD, Antinori A (2000). The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis
182: 1077–1083.
Article
PubMed
Google Scholar
Du Pasquier RA, Koralnik IJ (2003). Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J NeuroVirol
9(Suppl 1): 25–31.
PubMed
Google Scholar
Du Pasquier RA, Kuroda MJ, Schmitz JE, Zheng Y, Martin K, Peyerl FW, Lifton M, Gorgone D, Autissier P, Letvin NL, Koralnik IJ (2003). Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol
77: 11918–11926.
Article
PubMed
Google Scholar
Hoffmann C, Horst HA, Albrecht H, Schlote W (2003). Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatment. J Neurol Neurosurg Psychiatry
74: 1142–1144.
CAS
Article
PubMed
Google Scholar
Hou J, Major EO (1998). The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J NeuroVirol
4: 451–456.
CAS
Article
PubMed
Google Scholar
Koralnik IJ (2002). Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J NeuroVirol
8(Suppl 2): 59–65.
CAS
Article
PubMed
Google Scholar
Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL (1999). JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology
52: 253–260.
CAS
PubMed
Google Scholar
Koralnik IJ, Du Pasquier RA, Kuroda MJ, Schmitz JE, Dang X, Zheng Y, Lifton M, Letvin NL (2002). Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol
168: 499–504.
CAS
PubMed
Google Scholar
Kwak EJ, Vilchez RA, Randhawa P, Shapiro R, Butel JS, Kusne S (2002). Pathogenesis and management of polyomavirus infection in transplant recipients, Clin Infect Dis
35: 1081–1087.
Article
PubMed
Google Scholar
Lewis MB, Howdle PD (2003). Neurologic complications of liver transplantation in adults. Neurology
61: 1174–1178.
CAS
PubMed
Google Scholar
Mader I, Herrlinger U, Klose U, Schmidt F, Kuker W (2003). Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology
45: 717–721.
CAS
Article
PubMed
Google Scholar
Mamidi A, De Simone JA, Pomerantz RJ (2002). Central nervous system infections in individuals with HIV-1 infection. J NeuroVirol
8: 158–167.
Article
PubMed
Google Scholar
Martinez AJ, Ahdab-Barmada M (1993). The neuropathology of liver transplantation: comparison of main complications in children and adults. Mod Pathol
6: 25–32.
CAS
PubMed
Google Scholar
Mueller XM (2004). Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants. Ann Thorac Surg
77: 354–362.
Article
PubMed
Google Scholar
Post MJ, Yiannoutsos C, Simpson D, Booss J, Clifford DB, Cohen B, McArthur JC, Hall CD (1999). Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol
20: 1896–1906.
CAS
PubMed
Google Scholar
Power C, Gladden JG, Halliday W, Del Bigio MR, Nath A, Ni W, Major EO, Blanchard J, Mowat M (2000). AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. In: Neurology, 57, pp 743–746.
Google Scholar
Seth P, Diaz F, Major EO (2003). Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. J NeuroVirol
9: 236–246.
CAS
PubMed
Google Scholar
Thurnher MM, Post MJ, Rieger A, Kleibl-Popov C, Loewe C, Schindler E (2001). Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol
22: 977–984.
CAS
PubMed
Google Scholar
Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ, Schulz-Schaeffer WJ, Kretzschmar HA, Enzensberger W, Hunsmann G, Luke W (1997). Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis
176: 250–254.
CAS
Article
PubMed
Google Scholar
Wijdicks EF (2001). Neurotoxicity of immunosuppressive drugs. Liver Transpl
7: 937–942.
CAS
Article
PubMed
Google Scholar